Published August 24, 2011 | Version v1
Journal article Metadata-only

Clinical management of gastric cancer: results of a multicentre survey

Creators

  • 1. The Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041 (China)
  • 2. The Department of Radiation Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041 (China)
  • 3. West China School of Public Health, Sichuan University, No.17 Section 3, Renmin South Road, Chengdu, Sichuan, 610044 (China)
  • 4. The Department of Medical Oncology, Sichuan Cancer Hospital, No.55, Ren Min Nan Road Si Duan, Chengdu, Sichuan, 610041 (China)
  • 5. Oncology Department, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, No.32, First Ring Road Xi Er Duan, Chengdu, Sichuan, 610041 (China)
  • 6. The Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041 (China)
  • 7. The Department of Medical Oncology, Yunnan Cancer Hospital, Ren Min Xi Road, Kunming, Yunnan, 650001 (China)
  • 8. The Department of Medical Oncology, Affiliated Hospital of Xinjiang Medical College, No.1, Liyushan Road, Urumqi, Xiangjiang, 830054 (China)

Description

The National Comprehensive Cancer Network clinical practice guidelines in oncology-gastric cancer guidelines have been widely used to provide appropriate recommendations for the treatment of patients with gastric cancer. The aim of this study was to examine the adherence of surgical oncologists, medical oncologists, and radiation oncologists' to the recommended guidelines. A questionnaire asking the treatment options for gastric cancer cases was sent to 394 Chinese oncology specialists, including surgical oncologists, medical oncologists, and radiation oncologists working in hospitals joined in The Western Cooperative Gastrointestinal Oncology Group of China. The questionnaire involved a series of clinical scenarios regarding the interpretation of surgery, neoadjuvant, adjuvant, and advanced treatment planning of gastric cancer. Analysis of 358 respondents (91%) showed variations between each specialization and from the recommended guidelines in the management approaches to specific clinical scenarios. The majority of specialists admitted that less than 50% of patients received multidisciplinary evaluation before treatment. The participants gave different responses to questions involving adjuvant, neoadjuvant, and advanced settings, compared to the recommended guidelines. These results highlight the heterogeneity of the treatment of gastric cancer. Surgical oncologists, medical oncologists, and radiation oncologists are not adhering to the recommended guidelines

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-11-369; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224384

Additional details

Identifiers

URL
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224384;
DOI
10.1186/1471-2407-11-369;

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
11
Journal Page Range
p. 369
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46102655
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CHINA; COOPERATIVES; HOSPITALS; NEOPLASMS; PATIENTS; PLANNING; RECOMMENDATIONS; SURGERY; VARIATIONS
Descriptors DEC
ASIA; BUILDINGS; DISEASES; MEDICAL ESTABLISHMENTS; MEDICINE

Optional Information

Copyright
Copyright (c)2011 Zhang et al
Notes
PMCID: PMC3224384; PUBLISHER-ID: 1471-2407-11-369; PMID: 21864355; OAI: oai:pubmedcentral.nih.gov:3224384; licensee BioMed Central Ltd.